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AbsTrACT
background Functional cognitive disorder (FCD) 
describes cognitive dysfunction in the absence of an 
organic cause. it is increasingly prevalent in healthcare 
settings yet its key neuropsychological features have not 
been reported in large patient cohorts. we hypothesised 
that cognitive profiles in fibromyalgia (FM), chronic 
fatigue syndrome (CFS) and functional neurological 
disorders (FNDs) would provide a template for 
characterising FCD.
Methods we conducted a systematic review of studies 
with cognition-related outcomes in FM, CFS and FND.
results we selected 52 studies on FM, 95 on CFS and 
39 on FND. we found a general discordance between 
high rates of subjective cognitive symptoms, including 
forgetfulness, distractibility and word-finding difficulties, 
and inconsistent objective neuropsychological deficits. 
Objective deficits were reported, including poor selective 
and divided attention, slow information processing and 
vulnerability to distraction. in some studies, cognitive 
performance was inversely correlated with pain, exertion 
and fatigue. Performance validity testing demonstrated 
poor effort in only a minority of subjects, and patients 
with CFS showed a heightened perception of effort.
Discussion The cognitive profiles of FM, CFS and non-
cognitive FND are similar to the proposed features of 
FCD, suggesting common mechanistic underpinnings. 
Similar findings have been reported in patients with mild 
traumatic brain injury and whiplash. we hypothesise 
that pain, fatigue and excessive interoceptive monitoring 
produce a decrease in externally directed attention. 
This increases susceptibility to distraction and slows 
information processing, interfering with cognitive 
function, in particular multitasking. Routine cognitive 
processes are experienced as unduly effortful. This may 
reflect a switch from an automatic to a less efficient 
controlled or explicit cognitive mode, a mechanism that 
has also been proposed for impaired motor control in 
FND. These experiences might then be overinterpreted 
due to memory perfectionism and heightened self-
monitoring of cognitive performance.
InTroDuCTIon
Practitioners in several settings report an increase 
in patients presenting with non-dementia cogni-
tive symptoms in recent years.1–3 Notably, a range 
of benign cognitive symptoms are experienced by 
between 5% and 32% of healthy young adults.4 
The term functional cognitive disorder (FCD) (or 
functional memory disorder) has been proposed 
to describe the subjective experience of cognitive 
dysfunction in the absence of underlying brain 
pathology.5–8 In common with historical practice 
in other functional neurological disorders (FNDs), 
the approach of cognitive specialists towards FCD 
has largely been to ‘rule out’ organic causes, rather 
than making an affirmative diagnosis on the basis of 
distinctive clinical features.9 
Typical symptoms of FCD include forgetting 
tasks while preparing to execute them, inability 
to retrieve overlearnt memories, disrupted flow of 
thoughts and conversations, prospective memory 
failures and absent-mindedness.5 6 9 These burden-
some symptoms are believed to occur in the absence 
of relevant objective deficits on neuropsychological 
assessment, that is, a discrepancy between subjec-
tive experience and objective performance, which 
is a canonical feature of FNDs.8 10 However, neuro-
psychological data on large cohorts of patients with 
FCD have not been reported. FCD is not a trivial 
disorder, with many patients continuing to experi-
ence distressing cognitive symptoms for months to 
years.8
Theoretically, FCD is proposed to be under-
pinned by psychological factors such as memory 
perfectionism, overinterpretation of attentional 
lapses and heightened self-monitoring for cogni-
tive errors.5 6 11 However, the empirical evidence 
supporting this model is modest.
FCD is considered part of the spectrum of FND 
(also known as conversion disorder).6 FNDs in 
general are characterised by both ‘internal’ incon-
sistency and incongruity with other neurological 
disorders (‘external' inconsistency).12 With respect 
to FCD, internal inconsistency can be demon-
strated, for example, by patients being able to 
provide detailed accounts of their memory lapses, 
while distinctive phenomenological differences 
with organic cognitive disorders constitute external 
inconsistency.13
People with FND most commonly present with 
abnormalities of movement control (eg, weakness, 
tremor and dystonic posturing) or attacks that 
resemble epilepsy (dissociative seizures/non-epi-
leptic attacks). Theories regarding the underlying 
neurobiology of FND suggest a central role for 
misdirected attention towards movement/sensa-
tion.14 Of note, people with FND presenting 
with movement disorder or dissociative seizures 
commonly report cognitive difficulties.9
There is ongoing debate regarding the relevance 
of the growing pathophysiological understanding of 
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FND to people who have chronic pain or chronic fatigue, who 
are typically diagnosed with fibromyalgia (FM) or chronic fatigue 
syndrome (CFS). FM and CFS can be regarded as functional 
somatic syndromes, a group of conditions affecting different 
body systems, but which are argued to have overlapping clin-
ical and aetiological characteristics.15 In our clinical practice, it 
is very common to see patients with FND and comorbid FM 
and/or CFS. Importantly, FM and CFS are also associated with 
subjective cognitive difficulties, sometimes referred to as ‘brain 
fog’.6 16–18
The relationship between archetypal FCD and cognitive 
symptoms in the context of FM, CFS and FND remains unclear. 
Furthermore, the extent to which cognitive difficulties in 
these conditions are separate or overlapping disorders has not 
previously been studied. However, the extensive literature on 
cognitive symptomatology in these conditions affords an oppor-
tunity to compare them and to consider whether the cognitive 
symptoms of FND, FM, and CFS provide a template for under-
standing the emerging concept of FCD.
We conducted a systematic review of cognitive findings in 
patients with FM, CFS and FND, in order to define their key 
neuropsychological characteristics. Our hypothesis was that 
the cognitive profiles associated with functional motor, fatigue 
and pain syndromes would be similar to each other and to that 
proposed for isolated FCD. This would support the existence of 
a shared causal mechanism contributing to cognitive symptoms 
in these conditions with important implications for diagnosis 
and treatment.
MeThoDs
We performed a systematic review of studies with cognition-re-
lated outcomes in FND, FM and CFS. The protocol was regis-
tered with the PROSPERO database (CRD42017072044). 
Outcomes included self-reported cognitive difficulties and defi-
cits on objective neuropsychological assessment.
More specifically, we planned to analyse and compare evidence 
regarding: cognitive symptoms; objective neuropsychological 
abnormalities (memory, attention and executive functions, infor-
mation processing, language and social cognition); consistency 
on repeat assessment; performance validity testing (PVT); and 
concordance between self-reported symptoms and objective 
cognitive deficits. These domains were defined based on our 
aims, previous knowledge and preliminary review of the litera-
ture, including relevant review articles.
We searched PubMed and hand-searched reference lists for 
articles published in English language. JDI, MJE and TT defined 
search strategy and selection criteria. TT searched PubMed, 
hand-searched relevant reference lists and selected studies 
for inclusion in the final qualitative analysis. Further details 
regarding study identification (including ‘search terms’) can be 
found in the online (supplementary PRISMA diagrams for FND, 
FM and CFS studies) .
Study quality was assessed based on: use of a control group, 
inclusion of PVT and blinding of neuropsychological assess-
ment. A summary of the methodology and main findings of each 
selected study for each condition can also be found in the online 
(supplementary summary tables from FND, FM and studies).
resulTs: evIDenCe for AbnorMAl CognITIon In fM, 
Cfs AnD fnD
For our final qualitative analysis (table 1), we selected 39 studies 
on FND including functional movement disorders (FMDs) 
and non-epileptic attacks (NEAs), 52 studies on FM and 95 
on CFS. Further details regarding study selection, including 
PRISMA flow diagrams, can be found in the online supplemen-
tary materials. Study characteristics were highly heterogeneous. 
In general, the evidence was scarcer for FND, including only 
one study assessing the neuropsychological profile of patients 
with FMD.19 We characterise each study in more detail in the 
supplementary materials (supplementary summary tables from 
FND, FM and studies). Here we present a summary of the main 
findings, organised by topic and condition (table 1).
Cognitive symptoms
Fibromyalgia
Patients with FM reported cognitive difficulties including forget-
fulness, distractibility, speech/language difficulties and disorgan-
ised thinking.20–24 The proportion of patients reporting cognitive 
symptoms ranged from around 50% to 90%.20 23 24 This prev-
alence was higher than in healthy controls21 or controls with 
rheumatic disorders.22–24 Contributing factors included pain, 
fatigue, depressed mood and poor sleep.22
Chronic fatigue syndrome
Patients with CFS often experienced cognitive symptoms, 
including poor memory, impaired attention and word-finding 
and reasoning difficulties.25–39 The proportion of affected 
patients ranged from around 70 up to 90%.25–28 Cognitive diffi-
culties were more prevalent than in healthy subjects.24 27 Coex-
isting fatigue,28 38 40 depression,26 28 38 40 41 anxiety26 31 38 41 and 
pain29 contributed to but did not entirely account for the severity 
of cognitive symptoms.26
Functional neurological disorder
A relatively small number of studies have investigated cognitive 
symptoms in patients with FND (including FMD19 and NEA42–45), 
with only one19 enrolling healthy controls. Patients with FMD 
reported more cognitive complaints than healthy subjects (50% 
vs 9.1%).19 Patients who had NEA reported more prominent 
cognitive difficulties in memory,42 attention/concentration42 
and language42 43 domains than controls with epilepsy. Cogni-
tive symptoms were correlated with the presence of depressed 
mood42 44 and post-traumatic stress disorder (PTSD).45
objective neuropsychological abnormalities
Memory
fibromyalgia 
Selective memory impairment was observed in tests that 
included stimulus competition,46 did not allow information 
rehearsal,47 were vulnerable to distraction48 and/or required 
sustained effort.49 Grisart et al50 reported an impairment of 
explicit memory contrasting with a preservation of automatic 
memory processes. A further study reported abnormalities in 
implicit memory.51
Abnormal working memory was correlated with pain48 52 53 
and anxiety48 but not with depression.48 52 53 Episodic memory 
impairment was correlated with pain51 52 and depression,49 but 
other studies did not find a link with comorbidities.50 54 
Chronic fatigue syndrome 
Working memory was often reported to be abnormal only in 
more effortful tasks, and this pattern was attributed to poor 
attention and slow information processing.34 55–58
Memory registration and consolidation were predominantly 
impaired relative to memory retrieval,31 59–61 which might 
reflect disruption of information acquisition and encoding 
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by distraction.59 However, poor retrieval has also been 
described.62 63
Predominant impairment of verbal relative to visual memory 
has been described in some studies.28 64–66 However, other studies 
observed that both verbal and visual domains were affected,67–69 
while others failed to demonstrate significant impairment of any 
memory domain.70–75
functional neurological disorder 
When compared with healthy subjects, patients with FMD had 
an isolated deficit on one verbal memory test,19 and patients 
who had NEA had a selective impairment of spatial working 
memory, associated with poor attention.76 In comparison with 
normative data, patients who had NEA demonstrated memory 
abnormalities,77 78 including impairment of working memory 
associated with poor attention and processing speed.79 However, 
normal memory performance has also been reported.80 Patients 
who had NEA performed similarly,80–85 similarly/better43 79 or 
better44 86 87 than patients with epileptic seizures (ESs).
Memory impairment was correlated with longer disease 
duration87 and psychopathology,87 including PTSD (along with 
substance abuse and use of psychopharmacological medica-
tion),45 low mood44 and anxiety.43
In summary, the available evidence is heterogeneous but 
does not support a global impairment of memory in FM, CFS 
or FND. However, some specific abnormalities have been 
described, which might reflect the effects of increased vulnera-
bility to distraction on memory performance.
Attention and executive function
Attention, executive function and working memory are closely 
interlinked. Indeed, storage and processing of items in working 
memory depends on attentional mechanisms. Moreover, 
executive function includes the ability to manage sources of 
distraction.17
fibromyalgia 
Abnormal attention has been related to an increased vulnerability 
of memory and other cognitive processes to distraction.46 48 52 88–90 
However, some studies argue against a generalised impairment 
of attention.91–95
Miró et al88 observed a selective impairment of ‘alerting’ 
and ‘executive control’ but not of ‘orienting’ components of 
attention (Attentional Network Test-Interactions). Impaired 
cognitive inhibition has been related to an inability to filter 
distracting information, underpinning the vulnerability to 
distraction.46 47 96 However, a specific impairment in cognitive 
inhibition was not confirmed in two studies.97 98 Overall, the 
evidence for abnormal executive function is mixed.91 93–95 99 100
Pain might exhaust attentional resources, thereby increasing 
susceptibility to distraction. An association between perfor-
mance on cognitive tests probing attention and pain89 and 
measures of central sensitisation90 has been described. However, 
another study did not confirm this relationship.88 Additionally, 
attentional bias towards emotionally negative information may 
capture additional processing resources.101
Chronic fatigue syndrome
Patients with CFS do not appear to show generalised abnormal-
ities of attention. However, prominent impairment of divided 
attention has been reported.102 Abnormalities on the Paced Audi-
tory Serial Addition Test (PASAT) and Paced Visual Serial Addi-
tion Test have been repeatedly observed in CFS.31 57 62 63 69 75 103–106 
Abnormal performance on these tests may also reflect poor 
divided attention.107
Impaired divided attention might account for poor perfor-
mance on more effortful attentional tasks.34 108 109 Patients with 
CFS might be particularly prone to distraction by irrelevant 
stimuli, as suggested by impairment on the Stroop interference 
task.27 32 110 However, this finding was not confirmed in all 
studies.25 35 111 112 Attentional bias to threat113 114 and towards 
emotionally negative information115 have been observed. 
However, others did not confirm a bias towards illness-related 
information.116 117
A selective impairment of executive function of attention 
has been described.118 Abnormal executive attention has been 
related to cause slowing of information processing118 and an 
attentional bias to threat.113 114 Other studies have observed 
abnormalities in executive functions.60 66 71 75 119 120 Finally, 
impairments of selective and sustained attention and cogni-
tive inhibition have been reported in subjects with comorbid 
FM.121 122
Functional neurological disorder
In comparison with healthy subjects, patients who had NEA, 
but not those with FMD, have been reported to have poor 
attention.19 76 81 This was associated with abnormal working 
memory,76 while executive functions were generally normal.76 81 
In comparison with normative data, patients who had NEA 
demonstrated abnormalities in attention (associated with poor 
processing speed and working memory).42 77 79 In compar-
ison with patients with ES, patients who had NEA performed 
similarly on tests of attention43 44 80 83 85 and executive func-
tion,80 82 87 with just one study reporting worse performance on 
attention.79
Overall, evidence across FM, CFS and FND suggests an 
impairment of selective and/or divided attention.
Information processing
Fibromyalgia
Evidence for impaired information processing as probed by 
PASAT is mixed, with some studies reporting abnormalities46 48 
and others normal performance.93 94 On 10 measures of infor-
mation processing speed, patients with FM only performed 
worse than controls with memory complaints in Stroop colour 
and word naming; this was proposed to reflect delayed lexical 
access.93 Some studies did not confirm slower information 
processing or psychomotor speed.52 94 95 Reduced processing 
speed in mental arithmetic has been correlated with pain and 
opiate medication but not with depression, anxiety, fatigue and 
sleep disturbance.123
Chronic fatigue syndrome 
Impaired information processing, as measured using PASAT, has 
been repeatedly reported.31 57 62 63 69 103–106 Information processing 
is related to attention, as it is thought to depend on how fast the 
attentional system operates. Notably, there was an association 
between poor divided attention and an impairment of informa-
tion processing in more challenging settings, where patients need 
to allocate attention resources to multiple tasks.31 55 However, 
several authors failed to confirm an impairment of information 
processing36 39 41 71 119 124 and/or psychomotor slowing.25 39 64 
When present, poor information processing was independent of 
depression,31 57 62 63 69 103 106 and the contribution of fatigue was 
inconsistent.31 106 109 125
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functional neurological disorder 
In comparison with healthy subjects, patients who had NEA, but 
not those with FMD, showed poor information processing.19 81 
In comparison with normative data, patients who had NEA also 
showed slow processing speed, along with poor attention and 
working memory.79 Patients who had NEA performed similarly 
to patients with ES in tests where information processing plays a 
role.43 79 81 83 85 On tests of psychomotor speed, patients who had 
NEA performed less well than healthy subjects81 and similarly 
to81 87 or worse82 than patients with ES.
language and other cognitive domains
fibromyalgia 
Verbal fluency provides a measure of how quickly and efficiently 
stored knowledge about words can be accessed.17 Patients with 
FM showed abnormal verbal fluency (and/or ‘verbal knowl-
edge’).52 91 93 126 Delayed lexical access has been proposed to 
contribute to difficulties finding words or understanding word 
meaning.126 It has been linked with psychomotor slowing99 and 
with coexisting depression.49 However, other studies did not 
support these associations.52 92 94
Chronic fatigue syndrome
Evidence regarding abnormal verbal fluency is conflicting, 
with some studies reporting impairment,125 127 128 others only 
selective abnormalities34 129 and others essentially normal 
performance.38 39 64 73 102 110 130 CFS twins performed similarly 
to non-fatigued twins and healthy subjects in tests of language 
and reasoning.112 Performance on the Boston Naming Test has 
been consistently normal,60 127 128 and several other studies 
report normal higher cognitive functions, including language63 
and abstract reasoning,103 130 131 although this last finding is 
not uniform.109 Language impairments including poor verbal 
fluency have been related to abnormal executive functioning but 
not with coexisting psychiatric disorders or use of psychoactive 
medication.128
functional neurological disorder 
Patients with FMD and healthy subjects performed similarly 
on verbal fluency tests.19 In comparison with normative data, 
patients who had NEA showed either naming and/or fluency 
abnormalities,42 78 79 or normal performances on a composite 
language score including naming, verbal comprehension and 
vocabulary.80 In comparison with patients with ES, patients 
who had NEA showed similar79 82 83 or better43 44 78 81 85 87 
performance on language assessment (including confrontational 
naming, verbal fluency, verbal comprehension and/or writing 
speed). Longer disease duration was correlated with poorer 
scores in a language composite including naming, fluency, 
reading and comprehension.87
social cognition
Social cognition refers to the ability to decipher information 
about the intentions and affective states of others. This capacity 
is crucial for the implementation of appropriate behaviour 
during social interactions. We did not find studies assessing 
social cognition in CFS.
fibromyalgia 
Patients with FM showed impaired recognition of others’ 
emotions, impaired representation of other people’s affec-
tive mental states and higher levels of alexithymia but normal 
empathy quotients.91 These deficits were independent of 
executive function and depression/anxiety. Poor emotional 
face recognition has been associated with pain and, to a lesser 
degree, with depression, anxiety and alexithymia.132 Abnormal 
social cognition has been related to interoceptive impairment,133 
as well as with an interference of nociception with cognitive 
and emotional processing, due to the partial overlap of brain 
networks involved in pain processing and face recognition.
functional neurological disorder 
Alexithymia is characterised by an inability to identify emotions 
at a cognitive level and has been repeatedly demonstrated in 
FND,76 134 135 although not uniformly.136 Patients who had NEA 
showed worse affect expression and recognition,43 impaired 
ability to switch between emotion and non-emotion face cate-
gorisation,137 positive attentional bias towards socially threat-
ening stimuli138 and an overall greater intensity of emotional 
experience and diminished positive emotional behaviour on 
exposure to pleasant, neutral and unpleasant pictures.139 As an 
exception, normal facial expression recognition has also been 
described.135
Consistency on repeat assessment
Chronic fatigue syndrome 
Patients with CFS showed an increased intraindividual variability 
on performance on repeated neuropsychological testing.140 
Significant variability of self-reported mental fatigue was also 
observed on repeated assessment.141
These findings can be regarded as evidence for internal incon-
sistency, which is considered a cardinal feature of functional 
neurological symptoms in general.6
Discrepancies between self-reported cognitive difficulties 
and objective assessment
fibromyalgia 
Although self-reported difficulties are prominent, evidence 
for objective cognitive impairment is far more contradictory, 
suggesting an overestimation of cognitive problems. Unfortu-
nately, only a handful of studies directly compared symptoms 
with objective performance. In two studies, prominent memory 
symptoms were disproportionate to objective impairment,48 94 
particularly after controlling for fatigue, pain and depression.94 
However, another observed a correlation between memory 
difficulties and objective performance.142 Cognitive symptoms 
have been associated with objective abnormalities in attention, 
processing speed, memory and executive functions.52 98
Chronic fatigue syndrome 
Prominent reported difficulties in memory,25 38 124 attention/
concentration,25 124 information processing124 and general 
cognitive function30 38 131 143 contrast with little or no deficit on 
objective assessment.25 30 38 124 131 143 Notably, prominent symp-
toms have been associated with impairment in only a minority 
of patients.28 Others observed a restricted pattern of neuro-
psychological impairment, involving attention/concentration, 
information processing and/or memory domains in the context 
of multiple, multimodal cognitive symptoms.26 63 73 Finally, a 
correlation between subjective and objective deficits has also 
been described, involving memory, attention and processing 
speed.27 31–34 55 108 111 144
‘Metamemory’ corresponds to self-knowledge about one’s 
own memory capabilities. Impossibly high standards of personal 
performance might contribute to discrepancies between self-re-
ported and objective abnormalities. This has been related to a 
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tendency to underestimate actual performance relative to expec-
tations of ‘normal’ performance.35 Contrary to this hypothesis, 
two studies observed normal estimations of memory abilities and 
corresponding objective performance.30 60
Functional neurological disorder
A discrepancy between prominent symptoms and relatively 
normal objective performance has been observed in a few 
studies.19 43 44 However, in one of these, this dissociation was 
observed in only one among several cognitive domains.43 More-
over, another study found discrepancies in patients who had 
NEA and in those with ES.42
Performance validity testing (PvT)
PVT was rarely included in test batteries assessing cognition in 
patients with FM or CFS. This is important in determining the 
cause of any underperformance on neuropsychological assess-
ment. However, the few studies including PVT did not demon-
strate a generalised lack of effort.
fibromyalgia 
Only a minority of patients with FM demonstrated suboptimal 
effort in the few studies that included PVT. However, the majority 
of participants performed normally on validity testing.94 145–148
The percentage of patients with FM passing PVT ranged 
from 63% in Johnson-Greene et al148 and Brooks et al,147 which 
included subjects receiving or seeking disability benefits or with 
possible secondary gains, to up to 100% in Iverson et al,145 
where patients were not involved in disability benefits assess-
ments. In Gervais et al,146 65% patients with FM who were on 
or seeking benefits performed in the normal range on PVT, and 
this percentage increased to 96% among those not seeking or 
receiving benefits. Poor performance on PVT was correlated 
with prominent cognitive symptoms,146 Millon Clinical Multi-
axial Inventory-III scores, including somatoform, depression and 
anxiety subscales147 and pain and poor sleep.148 In one study, 
patients with FM showed prominent memory complaints but 
normal objective performance after excluding participants who 
demonstrated poor effort and controlling for pain, fatigue and 
depression.94
Chronic fatigue syndrome 
In Busichio et al75 the Test of Memory Malingering did not reveal 
lack of effort in any patient with CFS. In Constant et al,68 only 
2/25 patients with CFS scored under the consistency threshold 
on PVT. Notably, these studies reported objective impairments 
of attention, information processing, memory and motor 
speed.68 75 A couple of other studies reported lack of evidence of 
poor motivation or effort.67 71 118 140 149
A different but related observation is a heightened perception 
of effort or fatigue after repeated or more challenging cognitive 
testing, which has been correlated with worse performance on 
cognitive testing.36 131 149 150
functional neurological disorder 
Performance validity testing in studies of patients with FND has 
yielded heterogeneous results. Several studies reported worse 
performance than in controls,19 81 151 152 while others reported 
performance that was normal79 or similar to neurological disease 
control groups.151
The percentage of patients passing on PVT ranged from 
48.8%153 to 100%,79 with most studies suggesting that 
only a minority proportion of patients with FND fail effort 
testing.151 154 155 Increased failure in comparison with controls 
was reported by Drane et al153 but not confirmed by Dodrill82 
and other authors.19 155 Additionally, subjects with FND rarely 
scored below chance on forced-choice tests,81 152 154 which 
suggests that malingering is uncommon, at least in those patients 
with FND who are recruited to observational studies. Finally, the 
observation of ‘isolated’ effort deficits, contrasting with normal 
scores in many other neuropsychological tests also requiring 
‘effort’,19 raises the hypothesis that some tests of performance 
validity may be measuring a specific cognitive deficit rather than 
incomplete effort.
DIsCussIon
FND, FM and CFS appear to be associated with similar, promi-
nent cognitive symptoms, including forgetfulness, distractibility 
and word-finding difficulties. In contrast, generalised neuropsy-
chological deficits have not been demonstrated.
Nevertheless, our systematic analysis of the literature reveals 
several specific abnormalities in FM, CFS and, to a lesser extent, 
FND. Poor selective and divided attention and slow information 
processing are reported across these disorders (table 1). Memory 
symptoms might therefore reflect increased vulnerability to 
distraction, which interferes with memory registration.
Coexisting psychopathology is not robustly associated with 
cognitive difficulties.26 31 48 52 53 57 62 63 69 103 106 123 128 However, 
both subjective cognitive symptoms and objective cognitive defi-
cits correlate with pain in FM and with mental or physical exer-
tion and fatigue in CFS.
Overall, these conditions show a mismatch between promi-
nent cognitive symptoms and, at best, only selective objective 
abnormalities. Importantly, the few studies including PVT 
reported poor effort in only a small proportion of patients, with 
the exception of patients with FM receiving or seeking disability 
benefits, where one-third failed PVT.
The cognitive profiles of FM, CFS and non-cognitive FND 
share several features with the recently proposed FCD (table 1), 
including a disproportion between self-reported memory and 
word-finding difficulties and objective neuropsychological defi-
cits and a strong bias towards symptoms with a likely attentional 
basis.
Some key features proposed to underpin FCD, including 
memory perfectionism, overinterpretation of attentional lapses 
and heightened self-monitoring for cognitive errors, have not 
been widely investigated in these disorders. However, in the CFS 
literature, there is some evidence for unrealistic expectations of 
cognitive performance,34 while in FM, there are well-described 
alterations in interoceptive awareness.132 These findings suggest 
the possibility of common risk factors, but empirical evidence 
confirming the relevance of these findings remains sparse.
Interestingly, neuropsychological assessment in FCD has not 
shown deficits in straightforward tests of attention,8 10 suggesting 
that it is a lack of attentional reserve rather than inattention per 
se that underpins the subjective experience of cognitive impair-
ment. To date, however, the more complex tests of attention 
used in the literature on FND, CFS and FM have not been 
reported in an FCD cohort.
Reduced attentional reserve could increase susceptibility 
to distraction and slow information processing. Heightened 
distractibility and attentional lapses could then contribute to 
the subjective experience of memory impairment (figure 1). 
Abnormal attention might have a disproportionate impact on 
real-life multitasking, but be more difficult to measure using 
standard neuropsychological evaluation.102
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Excessive attention towards the body, severe pain and fatigue 
might underlie the decrease in externally directed attention. In 
the context of alexithymia, difficulties in recognising somatic 
markers of emotions might promote body monitoring and 
further exhaust attentional resources (figure 1).
 Memory perfectionism and heightened self-monitoring of 
cognitive processes and errors might then lead to overinterpreta-
tion of such attentional lapses in daily life which, in turn, could 
drive advice-seeking from healthcare professionals (figure 1). 
Interestingly, the ability to ‘normalise’ somatic experiences 
inversely correlates with health seeking behaviour in FM.156 
Perfectionism may be relevant in FM and CFS. Women with FM 
do not have greater perfectionist traits overall, but perfectionism 
correlates with poor health status.157 In CFS, self-critical perfec-
tionism has been shown to predict fatigue and pain levels.158 
However, the concept of memory perfectionism as a core feature 
of, or risk factor for, FCD needs further elucidation.
Another interesting observation is the heightened perception 
of effort after repeated or more challenging cognitive testing in 
patients with CFS.36 131 149 150 Heightened perception of effort 
is proposed to reflect an interpretive bias for somatic informa-
tion,116 a greater operational demand to control and monitor 
cognitive processes159 or a sense of insufficiency resulting from 
unrealistically high expectations about one’s performance, 
leading to an overestimation of exertion and fatigue.35
If present across this group of disorders, a heightened percep-
tion of cognitive effort may also contribute to the experience of 
illness, due to the extreme effort invested in otherwise trivial 
daily tasks. The experience of illness would then be decoupled, 
to a degree, from objective cognitive performance. Therefore, 
abnormal effort may well constitute a piece in the jigsaw of FCD.
Cognitive effort can be regarded as a cost of controlled cogni-
tive processes.160 A switch from an automatic to a controlled 
mode of cognitive processing may therefore underlie the 
increase in cognitive effort. Notably, this would mirror what 
is observed in FMD, where a switch from an automatic to an 
explicit (‘conscious’) mode of motor control impairs motor 
performance.161
In addition, the hypothetical switch from an automatic to a 
highly controlled (and effortful) cognitive operational mode 
could be a maladaptive attempt to compensate for ‘memory fail-
ures’ that were invested with pathological significance. Paradox-
ically, an exaggerated investment of effort could also contribute 
to the failure on performance validity testing by a minority of 
patients. Indeed, motivation depends on a cost–benefit anal-
ysis,162 and a ‘high effort’ operational mode could lead to earlier 
disengagement due to unacceptably high performance costs.
Although our systematic review focused on FND, FM and 
CFS, there are other conditions where prominent cognitive diffi-
culties contrast with inconsistent neuropsychological deficits and 
an absence of structural lesions on conventional neuroimaging.
Postconcussion syndrome (PCS) is characterised by a constel-
lation of ‘non-specific’ neuropsychiatric symptoms following a 
concussion or mild traumatic brain injury. Similarly to FND, FM 
and CFS, patients report poor concentration, mental slowness, 
forgetfulness and word-finding difficulties.163
Neuropsychological assessment in PCS does not confirm 
widespread cognitive deficits.164 However, specific abnormali-
ties in selective and divided attention, information processing 
and working memory have been described, again mirroring 
observations in FND, FM and CFS.165–168 This similarity was 
corroborated by direct comparisons between PCS and CFS.61
Whiplash syndrome follows a hyperflexion, hyperexten-
sion or hyperlateroversion of the neck without external head 
injury or loss of consciousness. Patients typically describe 
chronic pain involving neck/shoulders. Cognitive difficul-
ties and other associated symptoms are similar to PCS.169–171 
Notwithstanding the controversy regarding the inconsis-
tency of objective neuropsychological deficits, a meta-anal-
ysis reported objective abnormalities in attention, working 
figure 1 Proposed mechanisms underpinning cognitive difficulties across the spectrum of functional cognitive disorders spectrum.
 o
n
 25 M
ay 2018 by guest. Protected by copyright.
http://jnnp.bmj.com/
J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2017-317823 on 7 May 2018. Downloaded from 
8 Teodoro T, et al. J Neurol Neurosurg Psychiatry 2018;0:1–12. doi:10.1136/jnnp-2017-317823
Cognitive neurology
memory, immediate and delayed recall, visuomotor tracking 
and cognitive flexibility.172
Functional imaging studies in the disorders investigated here, 
as well as in PCS, have described dysfunction of a fronto-pa-
rieto-temporal network postulated to be involved in attention, 
memory and executive functions as well as in emotion and pain 
processing.36 173–179 This would provide a neurobiological basis 
for the proposed interaction between attention-related cognitive 
functions and abnormalities with pain and emotional processing 
as well as movement control.
Interestingly, negative expectations regarding the conse-
quences of a head injury and recall bias have both been impli-
cated in self-reported symptoms after concussion.180 181 This 
gains particular relevance given the proposed role of abnormal 
predictions or expectations in the pathogenesis of functional 
neurological symptoms.14
limitations
Evidence for the presence and characteristics of cogni-
tive abnormalities in FNDs, FM and CFS is remarkably 
heterogeneous.
Sample sizes were usually small, and a control group of 
healthy subjects was often lacking. In Vercoulen et al,28 
objective cognitive impairment in a minority of patients 
with CFS was sufficient to drive between-group differences 
towards statistical significance. In these disorders, population 
heterogeneity means that small sample sizes and the use of 
average scores (rather than, eg, the proportion of individ-
uals performing below threshold) might conceivably lead to 
false-positive results.
Notably, cognition in FND has been far less studied than 
in FM and CFS. Moreover, among 39 studies on FND, 36 
focused on NEA, 1 in neurological ‘medically unexplained 
symptoms’154 and only 2 on FMD.19 134 Although we decided 
to use the more encompassing term ‘FND’, available evidence 
does not allow us to conclude much about the cognitive profile 
of FMD. However, it would be reasonable to expect a degree 
of overlap among FND subtypes.
Patients with FM, CFS and FND are often treated with medi-
cations such as benzodiazepines or opioids, which can have 
cognitive side effects. Unfortunately, the possible contribu-
tion of medication to cognitive performance was infrequently 
assessed. Although blinding in neuropsychological evaluations 
was rare, the increased availability of computerised evalua-
tions might have helped reduce observer bias.
Despite the ongoing discussion about the discordance 
between subjective and objective abnormalities, relatively few 
studies investigated discrepancies within the same sample. 
In addition, PVT was rarely included in neuropsychological 
assessment, despite the pervasive belief that patients ‘exag-
gerate’ their symptoms, do not apply sufficient effort in cogni-
tive testing or may be seeking secondary gains.
The variety of methods used for PVT was striking. Further-
more, the definition of ‘poor effort’ was heterogeneous, 
including: scoring below chance in forced-choice tests, scoring 
below/above a prespecified cut-off proposed to distinguish 
‘poor effort’ and scoring lower than controls in PVT. It is 
important to highlight that poor effort does not necessarily 
equate to malingering or a factitious disorder. For example, 
patients with FM are frequently affected by performance 
anxiety, and one can imagine that it may interfere with falsely 
‘challenging’ effort tasks. Another contributor could be 
‘cogniphobia’, a concept akin to ‘kinesiophobia’ that reflects 
a reluctance to engage in any cognitive task, due to a fear that 
doing so may aggravate other symptoms.182
Finally, we acknowledge that there is ongoing debate about the 
aetiology and diagnosis of CFS and FM, in particular the rele-
vance or not of ‘organic’ and ‘non-organic’ factors.183 184 There is 
considerable debate, particularly with regard to CFS, about how 
to define and diagnose the condition, and indeed whether there 
may be a number of different conditions present within groups 
of patients diagnosed with CFS. We accept that these debates are 
important and as yet unresolved and that heterogeneity in the CFS 
and FM populations reviewed here might have reduced the power 
of studies to identify consistent deficits.
ConClusIon
Given the considerable heterogeneity in the literature and its 
methodological shortcomings, further research is warranted 
before reaching firm conclusions about the nature of cognitive 
difficulties in FND, CFS and FMD or the existence of an over-
arching ‘functional cognitive disorder spectrum’, also encom-
passing conditions such as PCS.
However, the available evidence does not support the exis-
tence of separate cognitive disorders in CFS, FM and FND. 
Rather, these conditions share common cognitive symptoms 
with an emphasis on attentional dysfunction. The newly 
emerging concept of FCD shares similar symptoms and 
hypothesised mechanistic underpinnings. Our understanding 
of these cognitive disorders and the development of novel 
interventions might be facilitated by regarding them as related 
conditions whose cognitive symptoms fall within the FCD 
spectrum, rather than as discrete entities. While evidence-
based treatment for FCD remains lacking, interventions for 
fatigue, pain and functional non-cognitive neurological symp-
toms are available.185–187 Therefore, practitioners assessing 
patients with FCD should look for these features, which 
may be missed if the consultation is exclusively focused on 
cognitive complaints. Clinical trials in FCD might reasonably 
also include subjects with CFS, FM or FND-related cognitive 
difficulties, which will generate larger sample sizes and lead 
to faster development of evidence-based treatment for this 
increasingly prevalent and distressing disorder. 
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